PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31004883-9	2019	Mechanistically, PAB treatment down-regulated the phosphorylation of STAT3, ERK1/2, and Akt.	pseudolaric acid B	17-20	AKT serine/threonine kinase 1	Homo sapiens	88-91	
31004883-12	2019	CONCLUSION: Taken together, our results suggest that PAB exerts anti-cancer activity in HCC cells through inhibition of STAT3, ERK1/2, Akt, and GSK-3beta/beta-catenin carcinogenic signaling pathways, and may be used as a phytomedicine in the treatment of HCC.	pseudolaric acid B	53-56	AKT serine/threonine kinase 1	Homo sapiens	135-138	
28132880-6	2017	We obtained further proof that PAB which could be used as a multi-targeted agent to inhibit the PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways and consequently suppress tumor growth and metastasis.	pseudolaric acid B	31-34	AKT serine/threonine kinase 1	Homo sapiens	101-104	
28132880-0	2017	Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways.	pseudolaric acid B	0-18	AKT serine/threonine kinase 1	Homo sapiens	122-125